Ledger.Open graph →
SEC Form D · filed March 21, 2025

Cime Therapeutics Inc

Offering
$2.5M
Sold
$2.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DENVER, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Chris T. Erickson · Denver, CODirectorJames T. Brewster Ii · Denver, COExec · DirectorJames T. Brewster Ii · Denver, COExec · DirectorChris T. Erickson · Denver, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗